Artelo Biosciences ARTL Cash Flow Statement (2014-2025)

NASDAQ ARTL
$5.98 -0.21 (-3.39%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Artelo Biosciences Quarterly Cash Flow Statement

Periods 47 quarters
Latest Dec 2025

Artelo Biosciences reported cash from operations of -$2.91M and free cash flow of -$2.91M for the quarter ended Dec 2025, down 13.4% year over year. This cash flow statement covers 47 quarters of results from May 2014 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income
-1.87M-2.25M-2.55M-1.90M-2.47M-2.40M-3.48M-2.29M-1.78M-2.61M-3.24M-2.59M-2.51M-1.20M-3.81M-2.37M-3.22M-3.19M-2.80M
Depreciation and DepletionDep. & Depletion
Share-based CompensationStock Comp.
0.34M2.86M2.86M0.62M0.62M0.61M0.61M508.61M0.51M519.11M0.22M0.76M0.76M0.76M0.20M0.77M0.81M0.75M0.37M
Gains from Investment SecuritiesGains Investment
0.02M0.01M
Cash from OperationsCash from Ops.
-0.89M-1.93M-2.05M-1.97M-1.70M-2.29M-2.19M-1.62M-1.80M-2.60M-2.94M-2.06M-0.78M-2.57M-1.60M-0.51M-3.50M-2.91M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
Depreciation & Amortization (CF)Dep. & Amort.
Change in Working Capital
Change in Account PayablesChange Payables
0.02M0.02M0.01M-0.02M0.03M0.03M-0.04M0.00M-0.02M0.05M-0.04M-0.01M0.03M-0.04M0.00M0.01M0.31M
Change in Accured ExpensesChange Accured Exp.
0.11M0.13M-0.16M-0.38M-0.02M0.55M-0.21M-0.19M0.33M0.37M-0.62M0.26M-0.26M1.08M0.80M2.25M-0.91M-0.83M
Other Working Capital ChangesOther WC Changes
Investing Activities
Capital ExpendituresCapex
Change in Acquisitions & DivestmentsChange Acquisitions
10.76M2.70M4.72M4.25M3.98M6.49M2.75M2.75M3.69M1.75M1.75M4.25M0.50M
Cash from Investing ActivitiesCash from Investing
8.37M-8.88M0.26M3.98M-3.08M1.80M2.20M0.40M-1.83M2.74M1.27M1.75M4.25M0.50M-0.25M0.19M
Financing Activities
Other financing activitiesOther financing
5.29M0.57M0.06M
Cash from Financing ActivitiesCash from Financing
5.32M18.26M-0.13M0.13M0.54M0.03M0.06M0.06M1.82M3.44M1.61M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
2,755.10M0.03M195.50M0.21M0.24M0.04M0.10M
Net Equity Issued and RepurchasedNet Equity Issued
1.01M18.26M0.54M0.03M0.06M0.06M1.08M1.76M1.76M
Additional items
Exchange Rate EffectFX Effect
0.04M-0.04M-0.02M-0.11M-0.21M0.12M0.01M0.03M0.02M-0.00M-0.00M-0.00M0.00M-0.01M0.01M0.02M-0.04M-0.00M
Change in Cash
3.32M7.42M-1.81M1.77M-4.99M-0.25M0.03M-1.20M-3.08M0.18M-1.62M-0.31M3.48M-2.02M-1.59M1.32M-0.35M-1.12M
Free Cash FlowFCF
-0.89M-1.93M-2.05M-1.97M-1.70M-2.29M-2.19M-1.62M-1.80M-2.60M-2.94M-2.06M-0.78M-2.57M-1.60M-0.51M-3.50M-2.91M
Net Cash FlowNCF
12.79M7.46M-1.80M1.89M-4.78M-0.36M0.01M-1.22M-3.10M0.18M-1.62M-0.31M3.47M-2.01M-1.60M1.30M-0.30M-1.12M